Efficacy and Tolerability of Exenatide Once Weekly Over 6 Years in Patients with Type 2 Diabetes: An Uncontrolled Open-Label Extension of the DURATION-1 Study

Background: Long-term treatment is necessary to slow the progression of type 2 diabetes (T2D). Here, we examined the safety and efficacy of 6 years of treatment with exenatide once weekly (QW) among patients with T2D in the DURATION-1 trial. Methods: The study enrolled patients aged ≥16 years with T...

Descripción completa

Detalles Bibliográficos
Autores principales: Henry, Robert R., Klein, Eric J., Han, Jenny, Iqbal, Nayyar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124747/
https://www.ncbi.nlm.nih.gov/pubmed/27525540
http://dx.doi.org/10.1089/dia.2016.0107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124747/
https://www.ncbi.nlm.nih.gov/pubmed/27525540
http://dx.doi.org/10.1089/dia.2016.0107

Ejemplares similares